M&T Bank Corp lowered its stake in shares of U.S. Physical Therapy, Inc. (NYSE:USPH – Free Report) by 2.4% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 7,930 shares of the company’s stock after selling 196 shares during the quarter. M&T Bank Corp owned about 0.05% of U.S. Physical Therapy worth $574,000 at the end of the most recent quarter.
A number of other institutional investors also recently added to or reduced their stakes in the business. Proficio Capital Partners LLC acquired a new stake in shares of U.S. Physical Therapy during the 4th quarter worth $3,526,000. Raymond James Financial Inc. purchased a new position in U.S. Physical Therapy in the 4th quarter valued at about $6,240,000. PNC Financial Services Group Inc. boosted its position in U.S. Physical Therapy by 37.4% in the 4th quarter. PNC Financial Services Group Inc. now owns 4,605 shares of the company’s stock valued at $409,000 after buying an additional 1,254 shares during the last quarter. Amundi raised its stake in shares of U.S. Physical Therapy by 174.5% in the 4th quarter. Amundi now owns 7,286 shares of the company’s stock valued at $649,000 after purchasing an additional 4,632 shares in the last quarter. Finally, HighTower Advisors LLC raised its stake in shares of U.S. Physical Therapy by 2.5% in the 4th quarter. HighTower Advisors LLC now owns 4,833 shares of the company’s stock valued at $429,000 after purchasing an additional 119 shares in the last quarter.
U.S. Physical Therapy Price Performance
Shares of U.S. Physical Therapy stock opened at $73.12 on Wednesday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.17 and a current ratio of 1.17. The firm’s 50-day simple moving average is $76.69 and its 200-day simple moving average is $78.76. U.S. Physical Therapy, Inc. has a twelve month low of $62.77 and a twelve month high of $101.20. The firm has a market cap of $1.11 billion, a P/E ratio of 33.54, a price-to-earnings-growth ratio of 3.58 and a beta of 1.44.
U.S. Physical Therapy Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Friday, June 13th. Investors of record on Friday, May 23rd were issued a dividend of $0.45 per share. This represents a $1.80 dividend on an annualized basis and a yield of 2.46%. The ex-dividend date of this dividend was Friday, May 23rd. U.S. Physical Therapy’s dividend payout ratio is currently 82.57%.
Insider Buying and Selling at U.S. Physical Therapy
In other U.S. Physical Therapy news, Director Nancy Ham sold 400 shares of the company’s stock in a transaction on Thursday, June 12th. The shares were sold at an average price of $78.01, for a total transaction of $31,204.00. Following the sale, the director directly owned 2,594 shares of the company’s stock, valued at approximately $202,357.94. This represents a 13.36% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. 2.00% of the stock is owned by company insiders.
Analyst Ratings Changes
Several equities research analysts recently weighed in on USPH shares. Barrington Research reiterated an “outperform” rating and set a $98.00 price objective on shares of U.S. Physical Therapy in a research note on Tuesday, July 1st. JPMorgan Chase & Co. decreased their price objective on shares of U.S. Physical Therapy from $120.00 to $110.00 and set an “overweight” rating for the company in a report on Wednesday, March 19th. Wall Street Zen upgraded shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a report on Thursday, May 8th. Finally, JMP Securities restated a “market outperform” rating and set a $113.00 target price on shares of U.S. Physical Therapy in a report on Tuesday, April 22nd. Two research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $109.00.
Read Our Latest Stock Report on USPH
U.S. Physical Therapy Profile
U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
Read More
- Five stocks we like better than U.S. Physical Therapy
- How to Use High Beta Stocks to Maximize Your Investing Profits
- JPMorgan Q2 Results Affirm Dividend, Buybacks, & Growth
- Where Do I Find 52-Week Highs and Lows?
- Goldman Spotlights These 3 Stocks in Its Bullish S&P 500 Outlook
- 3 Best Fintech Stocks for a Portfolio Boost
- Fastenal Surges After Earnings Beat, Tariff Risks Loom
Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.